Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
Toubai T, Tanaka J, Ota S, Fukuhara T, Hashino S, Kondo T, Kasai M, Kakinoki Y, Masauzi N, Morioka M, Kawamura T, Iwasaki H, Asaka M, Imamura M. Toubai T, et al. Among authors: fukuhara t. Am J Hematol. 2005 Nov;80(3):181-7. doi: 10.1002/ajh.20461. Am J Hematol. 2005. PMID: 16247752 Free article.
Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia.
Kikuchi M, Tanaka J, Kondo T, Hashino S, Kasai M, Kurosawa M, Iwasaki H, Morioka M, Kawamura T, Masauzi N, Fukuhara T, Kakinoki Y, Kobayashi H, Noto S, Asaka M, Imamura M. Kikuchi M, et al. Among authors: fukuhara t. Int J Hematol. 2010 Oct;92(3):481-9. doi: 10.1007/s12185-010-0670-1. Epub 2010 Sep 10. Int J Hematol. 2010. PMID: 20830615 Free article.
[Current status of treatment for patients with idiopathic thrombocytopenic purpura in the Hokkaido area (evaluation of Helicobacter pylori eradication)].
Hashino S, Ota S, Kobayashi S, Tanaka J, Musashi M, Fukuhara T, Miyake T, Kurosawa M, Iwasaki H, Shiroshita N, Hirano T, Irie T, Morioka M, Noto S, Kobayashi H, Suzuki S, Kawamura T, Yamamoto Y, Kakinoki Y, Kobayashi N, Kasai M, Oya T, Hirano M, Tanaka M, Fujimoto N, Imamura M; Clinical Hematology Forum. Hashino S, et al. Among authors: fukuhara t. Rinsho Ketsueki. 2004 Jul;45(7):539-45. Rinsho Ketsueki. 2004. PMID: 15359913 Japanese.
Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients.
Toubai T, Tanaka J, Ota S, Fukuhara T, Hashino S, Kondo T, Shono Y, Morioka M, Kawamura T, Masauzi N, Kakinoki Y, Kobayashi H, Kunieda Y, Kasai M, Kurosawa M, Asaka M, Imamura M. Toubai T, et al. Among authors: fukuhara t. Eur J Haematol. 2006 Nov;77(5):403-9. doi: 10.1111/j.1600-0609.2006.00746.x. Epub 2006 Aug 23. Eur J Haematol. 2006. PMID: 16930137 Free article. Clinical Trial.
Effects of the mean daily doses of imatinib during the first year on survival of patients with chronic myeloid leukemia in Japan: a study of the Hokkaido Hematology Study Group.
Sugita J, Tanaka J, Kurosawa M, Fukuhara T, Hashino S, Torimoto E, Koizumi K, Masauji N, Nishimura S, Koda K, Imamura M, Kasai M; Hokkaido Hematology Study Group. Sugita J, et al. Among authors: fukuhara t. Eur J Haematol. 2008 Feb;80(2):160-3. doi: 10.1111/j.1600-0609.2007.00982.x. Epub 2007 Nov 17. Eur J Haematol. 2008. PMID: 18028432
Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.
Shigematsu A, Tanaka J, Suzuki R, Atsuta Y, Kawase T, Ito YM, Yamashita T, Fukuda T, Kumano K, Iwato K, Yoshiba F, Kanamori H, Kobayashi N, Fukuhara T, Morishima Y, Imamura M. Shigematsu A, et al. Among authors: fukuhara t. Int J Hematol. 2011 Nov;94(5):463-71. doi: 10.1007/s12185-011-0944-2. Epub 2011 Nov 1. Int J Hematol. 2011. PMID: 22042561 Free article.
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.
Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S, Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T. Torimoto Y, et al. Among authors: fukuhara t. Int J Hematol. 2013 Aug;98(2):171-8. doi: 10.1007/s12185-013-1383-z. Epub 2013 Jun 29. Int J Hematol. 2013. PMID: 23813410 Clinical Trial.
Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.
Hirayama Y, Ishitani K, Ota S, Kurosawa M, Kondo T, Takimoto R, Mori A, Sakai H, Torimoto Y, Yamamoto S, Sato K, Iwasaki H, Kohda K, Ishida T, Kakinoki Y, Fukuhara T, Kato J. Hirayama Y, et al. Among authors: fukuhara t. Int J Hematol. 2014 Sep;100(3):281-9. doi: 10.1007/s12185-014-1629-4. Epub 2014 Jul 23. Int J Hematol. 2014. PMID: 25052874
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T. Kurosawa M, et al. Among authors: fukuhara t. Int J Hematol. 2012 Dec;96(6):748-57. doi: 10.1007/s12185-012-1210-y. Epub 2012 Oct 31. Int J Hematol. 2012. PMID: 23111539
828 results